Načítá se...
The place of intravenous immunoglobulin in rheumatic diseases
Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Bar...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
IMA-PRESS LLC
2016-01-01
|
| Edice: | Современная ревматология |
| Témata: | |
| On-line přístup: | https://mrj.ima-press.net/mrj/article/view/655 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|